According to a recent SEC filing, Clinipace has raised $3 million in financing from an undisclosed investor.
Clinipace is a full-service, clinical research organization that aims to serve the needs of venture-backed, mid-tier, and strategic pharmaceutical, biotechnology, and medical device firms, helping them advance drug candidates to deliver successful stakeholder and patient outcomes. According to the company, it completed 1,500 clinical trials and 1,500 regulatory and statistical consulting projects in North America, South America, Europe, and Asia.